Learn More
Medchemexpress LLC [2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo... | 1627902-21-9 | MFCD31556312 | 99.3% | 440.78 g/mol | C18H13ClF4N6O | 10 MG

Supplier: Medchemexpress LLC HY11750810MG
JNJ-54175446 is a brain-penetrant, selective purine P2X7 receptor antagonist used in central nervous system research and clinical investigations of neuroinflammation and mood disorders. It is characterized by high potency at human and rat P2X7 receptors and is available in both solid and solution formats across multiple package sizes.
- Brain-penetrant P2X7 receptor antagonist.
- High potency: pIC50 8.46 (human), 8.81 (rat).
- Available as solid and DMSO solution; multiple package sizes from 1 mg to 500 mg.
- High reported purity of 99.3%.
- Suitable for in vitro and in vivo CNS pharmacology studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.